Core Viewpoint - Arcturus Therapeutics Holdings Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its focus on messenger RNA medicines for rare diseases and infectious disease vaccines [1] Company Overview - Arcturus Therapeutics is a commercial company specializing in messenger RNA medicines [1] - The company is focused on developing therapeutics for liver and respiratory rare diseases, as well as vaccines for infectious diseases [1] Event Details - Joseph Payne, the President & CEO of Arcturus, will present at the conference on January 12, 2026, at 5:15 p.m. Pacific Time [1]